SLC7A11 and hepatocellular carcinoma: It should be noted that SLC7A11 is significantly expressed in poorly differentiated HCC tissues [22], which is consistent with our findings, and the SLC7A11 inhibitor SASP enhances ROS-mediated apoptosis in CDDP-treated HCC cells.